$APP

AppLovin stock: Piper Sandler cuts rating after first guidance miss since IPO

Piper Sandler downgraded AppLovin (APP) to Neutral after its Q2 results, citing a slight miss versus revenue guidance midpoint by 30 bps and EBITDA by 100 bps, the first such miss since IPO. Management blamed model improvement timing, expected to reverse in Q3. Piper cut FY27 revenue and EBITDA estimates 2% and 3% and lowered its price target to $385 from $665.

Original reporting
Published Aug 6, 2026, 2:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 2:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$APP
Bearish
medium confidence
Mentioned
$APP
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$APPBearishMed
01

Why it matters

The key tradable takeaway is the combination of a rating downgrade, a sharp price-target cut, and reduced 2027 revenue and EBITDA estimates tied to AI model improvement execution risk.

02

Market read

A concrete sell-side catalyst (downgrade plus large PT cut) increases near-term sensitivity to any follow-through on Q3 reversal and future guidance.

03

What to watch

The note also flags mixed e-commerce messaging as a headwind; traders may be over-weighting the model-improvement cadence versus go-to-market clarity.

Relevance 7/10Novelty 6/10Timing: today’s analyst downgrade after Q2 results

Background

Piper Sandler’s note follows AppLovin’s Q2 results and frames the guidance miss as the first time it questioned the company’s enhancement cadence.

Company-level read

Ticker impact

$APPBearishMedium confidence
Context

Piper Sandler downgraded AppLovin to Neutral after Q2 missed revenue guidance midpoint and EBITDA midpoint for the first time since IPO.

Expected impact

Near-term downside bias as the rating cut and lower 2027 estimates reinforce valuation risk around beat/raise cadence.

Evidence & confidence

The article cites specific guidance misses (revenue and EBITDA midpoint) and a thesis that future compute or larger model improvements may be required, plus a large price-target reduction.

Market effects

Highlights investor sensitivity to AI-related cost and model-improvement cadence among ad-tech/AI platform names.

No specific regional impact described.

No direct global macro or cross-border catalyst beyond general AI jitters.

Counterpoint

Management expects the timing issue to reverse in Q3, so the miss may be more timing-related than a structural inability to hit guidance.

Key entities

  • AppLovin

    Subject of the downgrade after Q2 guidance midpoint misses and concerns about future directed model improvement magnitude/frequency.

  • Piper Sandler

    Downgraded AppLovin to Neutral and cut its fiscal 2027 estimates and price target.

  • James Callahan

    Authored the note citing revenue and EBITDA midpoint misses and uncertainty about beat/raise cadence.

Related articles

$APPMed

Applovin stock hits 52-week low at 341.42 USD

AppLovin shares fell to near a 52-week low around $341 to $343, down about 38% year-to-date, according to Investing.com. The article cites Q2 2026 revenue of $1.92B vs $1.95B expected and current-quarter guidance midpoint of $2.07B vs $2.08B. Several analysts cut price targets or ratings after the misses.

$APPMedAI 8/10

AppLovin (APP) Stock Trades Down, Here Is Why

AppLovin (NASDAQ: APP) shares fell 18.6% after the company reported Q2 2026 results below expectations. Revenue was $1.92B versus $1.95B estimates, and Q3 guidance was $2.07B versus $2.08B consensus, according to the company and analysts. Wells Fargo and Piper Sandler downgraded the stock, citing the revenue miss and growth concerns.

$APPMed

Dow slips, Nasdaq moves level as earnings keep markets on edge

U.S. stocks opened mixed as investors digested earnings and economic data. AppLovin (APP) fell over 20% after Q2 revenue of $1.924B missed estimates. Datadog (DDOG) dropped over 18% on weaker bookings and guidance. SpaceX (SPCX) rose about 2.5% after a lockup expiry. Western Digital (WDC) slid 11% on margin outlook; Fiserv (FI) and Kenvue (KVUE) also fell.

$APPMedAI 8/10

Why AppLovin Stock Tumbled Today

AppLovin (NASDAQ: APP) shares fell about 19.6% in early trading after the company reported Q2 results that missed expectations. Revenue rose 53% to $1.92B versus $1.94B consensus. GAAP EPS increased to $3.76, slightly above $3.75. Q3 revenue guidance of $2.055B-$2.085B and adjusted EBITDA outlook also trailed consensus.

$SNDKMed

Futures Flat As Tech Slides After Memory Stocks, Korea Tumble

US stock index futures were mixed, with S&P futures up 0.1% and Nasdaq futures down 0.5% as Sandisk (SNDK) fell about 9% and Western Digital (WDC) about 15% after earnings and weaker memory outlooks. Tech and AI names also dropped on results or guidance misses, while Mag 7 were mixed. Asian markets declined after chip-related losses, and investors awaited US payrolls.